Our rare oncology research experts have the experience and expertise to guide your clinical trials.
Juliet Moritz has worked in clinical research for more than 25 years, and her extensive background covers the spectrum from single-site studies to large, multinational trials. She joined Premier Research in 2016 to specialize in rare diseases, supporting the strategic development of products that address unmet medical needs associated with rare and orphan afflictions.
Prior to joining Premier Research, Ms. Moritz was Associate Director of Global Project Management at PPD, overseeing infectious and respiratory disease research, and prior to that was Associate Director of Clinical Research at Knopp Biosciences. She held senior positions at Wyeth, Theravance, and PPD and began her career as a clinical research associate.
Ms. Moritz holds a Master of Public Health degree from the Drexel University School of Public Health and a bachelor’s degree in biology from the University of Pennsylvania. She is a member of the National Organization for Rare Disorders and the Drug Information Association.
Executive Director, Oncology & General Medicine, Strategic Development
Sachin Kulkarni has 14 years of experience in clinical research and project management. As an Executive Director, Strategic Development, Mr. Kulkarni is responsible for providing the strategic planning, coordination, knowledge and expertise in a specific subject matter for a project or standalone consultative services. Mr. Kulkarni works with the office of project management to provide overall process improvements, roll out of new tools which in turn benefit the internal teams and sponsors as well.
At Premier Research, Mr. Kulkarni oversees projects that cover a broad therapeutic area that includes oncology, rare disease, analgesia, and gastrointestinal disorders. He has served as project manager for over some of the studies and has senior oversight of various other programs for clients.
Mr. Kulkarni previously worked at PPD as a Senior Project Manager with a focus on oncology trials and simultaneously worked on multiple Phase I studies as a project manager. Being involved with hematology and oncology trials that span from a single institution and single geographic region to large global studies, he fully understands the design and operational oversight of these trials.
Earlier in his career, Mr. Kulkarni worked for Fox Chase Cancer Center in Philadelphia a project manager for multiple research studies, developing patient recruitment plans.